Showing results (151-160 of 432) with videos related to
Sort By:
Pageof 44
International Journal of Cancer|January 14, 2014
Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trialsMatteo Santoni, Alessandro Conti, Francesco Massari, et al.Future Oncology (London, England)|July 11, 2015
Evolution in the treatment of gastroenteropancreatic-neuroendocrine neoplasms, focus on systemic therapeutic options: a systematic reviewSara Pusceddu, Filippo De Braud, Fabrizio Festinese, et al.Cancer Management and Research|October 24, 2022
Optimal Choice of Adjuvant Treatment for Renal Cell Carcinoma Following NephrectomyAchille Bottiglieri, Pierangela Sepe, Marco Stellato, et al.Cancer Chemotherapy and Pharmacology|August 29, 2006
Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?Emilio Bajetta, Laura Catena, Giuseppe Procopio, et al.Tumori|December 2, 2017
TARIBO trial: targeted therapy with or without nephrectomy in metastatic renal cell carcinoma: liquid biopsy for biomarkers discoveryElena Verzoni, Raffaele Ratta, Paolo Grassi, et al.Cancer Treatment Reviews|February 23, 2023
nmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectivesAlfredo Berruti, Sergio Bracarda, Orazio Caffo, et al.Cancer Treatment Reviews|November 27, 2018
Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectivesFrancesca Corti, Federico Nichetti, Alessandra Raimondi, et al.Journal of Cancer Metastasis and Treatment|November 15, 2021
RANBP9 as potential therapeutic target in non-small cell lung cancerAnna Tessari, Shimaa H A Soliman, Arturo Orlacchio, et al.Tumori|May 2, 2018
Entering the third decade of experience with octreotide LAR in neuroendocrine tumors: A review of current knowledgeSara Pusceddu, Natalie Prinzi, Alessandra Raimondi, et al.Critical Reviews in Oncology/Hematology|June 2, 2023
Digestive MiNENs: Could histological classification and molecular characterization drive clinical outcome and therapeutic approach?Laura Cattaneo, Giovanni Centonze, Giovanna Sabella, et al.Pageof 44